PEPconnect

Drug Levels, Bleeding, and Thrombotic Outcomes in Patients under Direct Oral Anticoagulants - Webinar

Since the DOAC availability in our Country, the “Italian Federation  of Thrombosis Diagnosis and Antithrombotic Management Centers” and the “Start register”, started the discussion on DOAC Safety Levels, to avoid both bleeding and thrombotic recurrencies.  We have developed experiences and evidences, at the same time we have established patient surveillance, in our antithrombotic centers. Experience has helped us define when to use laboratory tests as well as define the most useful for the purpose. 

  • Anticoagulation DOACs TAVR (Transcatheter Aortic Valve Replacement) CVD (cardiovascular disease) Bleeding MCI (Myocardial Infarction) Hemostasis cardiovascular diseases coronary artery disease antiplatelet therapy testing and monitoring direct oral anticoagulants direct oral anticoagulants